Antimicrobial resistance rates of Enterobacter spp.: A seven-year surveillance study

Medical Principles and Practice

Volumn 18, Issue 2, 2009, Pages 100-104

  Al Tawfiq, Jaffar A ^a   Antony, Amalraj ^a   Abed, Mahmoud S ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

Antimicrobial resistance; Enterobacter aerogenes; Enterobacter agglutinins; Enterobacter cloacae; Enterobacter spp.

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN; TICARCILLIN; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; HUMAN; IN VITRO STUDY; NONHUMAN; OUTPATIENT; SAUDI ARABIA;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER; SAUDI ARABIA;

EID: 60149088326     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000189806     Document Type: Article

References (21)

1. Kader AA, Kamath KA, Dass SM: Accelerated detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae. Br J Biomed Sci 2006;63:151-154.
2. El-Khizzi NA, Bakheshwain SM: Prevalence of extended-spectrum beta-lactamases among Enterobacteriaceae isolated from blood culture in a tertiary care hospital. Saudi Med J 2006;27:37-40.
3. El-Karsh T, Tawfik AF, Al-Shammary F, Al-Salah S, Kambal AM, Shibl AM: Antimicrobial resistance and prevalence of extended spectrum beta-lactamase among clinical isolates of Gram-negative bacteria in Riyadh. J Chemother 1995;7:509-514.
4. McGowan JE: Economic impact of antimicrobial resistance. Emerg Infect Dis 2001;7:286-292.
5. Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard, ed 7. Wayne, Clinical and Laboratory Standards Institute, 2006, M7-A7.
6. Huang SS, Labus BJ, Samuel MC, Wan DT, Reingold AL: Antibiotic resistance patterns of bacterial isolates from blood in San Francisco County, California, 1996-1999. Emerg Infect Dis 2002;8:195-201.
7. Al-Tawfiq JA: Increasing antibiotic resistance among isolates of Escherichia coli recovered from inpatients and outpatients in a Saudi Arabian hospital. Infect Control Hosp Epidemiol 2006;27:748-753.
8. Al-Tawfiq JA: Occurrence and antimicrobial resistance pattern of inpatient and outpatient isolates of Pseudomonas aeruginosa in a Saudi Arabian hospital: 1998-2003. Int J Infect Dis 2007;11:109-114.
9. Al-Tawfiq JA, Antony A: Antimicrobial resistance of Klebsiella pneumoniae in a Saudi Arabian hospital: results of a 6-year surveillance study, 1998-2003. J Infect Chemother 2007;13:230-234.
10. Raveh D, Rudensky B, Huerta M, Aviv Y, Yinnon AM: Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection. Eur J Clin Microbiol Infect Dis 2003;22:158-164.
11. Raveh D, Rudensky B, Schlesinger Y, Benenson S, Yinnon AM: Susceptibility trends in bacteraemias: analyses of 7,544 patient-unique bacteraemic episodes spanning 11 years (1990-2000). J Hosp Infect 2003;55:196-203.
12. Lockhart SR, Abramson MA, Beekmann SE, Gallagher G, Riedel S, Diekema DJ, Quinn JP, Doern GV: Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007;45:3352-3359.
13. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ: Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 2007;60:1018-1029.
14. Friedland I, Stinson L, Ikaiddi M, Harm S, Woods GL: Resistance in Enterobacteriaceae: results of a multicenter surveillance study, 1995-2000. Infect Control Hosp Epidemiol 2003;24:607-612.
15. Juanjuan D, Zhiyong Z, Xiaoju L, Yali X, Xihai Z, and Zhenzhen L: Retrospective analysis of bacteremia because of Enterobacter cloacae compared with Escherichia coli bacteremia. Int J Clin Pract 2007;61:583-588.
16. Livermore DM, James D, Reacher M, Graham C, Nichols T, Stephens P, Johnson AP, George RC: Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999. Emerg Infect Dis 2002;8:473-478.
17. Strahilevitz J, Engelstein D, Adler A, Temper V, Moses AE, Block C, Robicsek A: Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob Agents Chemother 2007;51:3001-3003.
18. Higgins PG, Fluit AC, Hafner D, Verhoef J, Schmitz FJ: Evidence of cross-resistance between ciprofloxacin and non-fluoroquinolones in European Gram-negative clinical isolates. J Antimicrob Chemother 2002;50:438-440.
19. Hanberger H, Burman LG, Cars O, Erlandsson M, Gill H, Nilsson LE, Nordlinder D, Walther SM, ICU STRAMA Study Group: Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Acta Anaesthesiol Scand 2007;51:937-941.
20. Mamishi S, Pourakbari B, Ashtiani MH, Hashemi FB: Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000. Int J Antimicrob Agents 2005;26:373-379.
21. DiPersio JR, Dowzicky MJ: Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. Int J Antimicrob Agents 2007;29:518-527.